Terms: = Head and neck cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
675 results:
1. Novel therapeutic strategies for rare mutations in non-small cell lung cancer.
Gou Q; Gou Q; Gan X; Xie Y
Sci Rep; 2024 May; 14(1):10317. PubMed ID: 38705930
[TBL] [Abstract] [Full Text] [Related]
2. Anaplastic and poorly differentiated thyroid carcinomas: genetic evidence of high-grade transformation from differentiated thyroid carcinoma.
Gu H; Wang J; Ran W; Li G; Hu S; Zhao H; Wang X; Wang J
J Pathol Clin Res; 2024 Mar; 10(2):e356. PubMed ID: 38602501
[TBL] [Abstract] [Full Text] [Related]
3. New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung cancer Focusing on
Saw SPL; Le X; Hendriks LEL; Remon J
Am Soc Clin Oncol Educ Book; 2024 Apr; 44(3):e432516. PubMed ID: 38560815
[TBL] [Abstract] [Full Text] [Related]
4. Reticular Myxoid Odontogenic Neoplasm with Novel STRN::alk Fusion: Report of 2 Cases in 3-Year-Old Males.
Rosebush MS; Smith MH; Cordell KG; Callahan N; Zaid W; Gagan J; Bishop JA
Head Neck Pathol; 2024 Mar; 18(1):26. PubMed ID: 38526831
[TBL] [Abstract] [Full Text] [Related]
5. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory alk-positive NSCLC from a phase II study.
Zheng J; Wang T; Yang Y; Huang J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Selvaggi G; Wang Y; Xiao S; Wang Q; Shen Z; Zhou J; Zhou J; Zhang L
Cancer Commun (Lond); 2024 Apr; 44(4):455-468. PubMed ID: 38421881
[TBL] [Abstract] [Full Text] [Related]
6. A systematic review and meta-analysis of mediastinoscopy-assisted transhiatal esophagectomy (MATHE).
Masuda Y; Leong EKF; So JBY; Shabbir A; Lam Jia Wei T; Chia DKA; Kim G
Surg Oncol; 2024 Apr; 53():102042. PubMed ID: 38330804
[TBL] [Abstract] [Full Text] [Related]
7. Radiation Dose Does Not Affect the Predictive Value of Thyroid Biopsy for Diagnosing Papillary Thyroid cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
[TBL] [Abstract] [Full Text] [Related]
8. Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer.
van der Zijden CJ; van der Sluis PC; Mostert B; Nuyttens JJME; Spaander MCW; Toxopeus ELA; Valkema R; Beerepoot LV; van Halteren HK; Lagarde SM; Wijnhoven BPL
Eur J Surg Oncol; 2024 Mar; 50(3):107968. PubMed ID: 38241878
[TBL] [Abstract] [Full Text] [Related]
9. Value of blood oxygenation level-dependent magnetic resonance imaging in early evaluation of the response and prognosis of esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a preliminary study.
Zheng H; Zhang H; Zhu Y; Wei X; Liu S; Ren W
BMC Med Imaging; 2024 Jan; 24(1):18. PubMed ID: 38216885
[TBL] [Abstract] [Full Text] [Related]
10. Mapping the impact of malnutrition as defined by the Global Leadership Initiative on Malnutrition and nutrition impact symptoms on the possibility of returning to work after treatment for head and neck cancer.
Einarsson S; Bokström A; Laurell G; Tiblom Ehrsson Y
Support Care Cancer; 2023 Dec; 32(1):55. PubMed ID: 38133825
[TBL] [Abstract] [Full Text] [Related]
11. Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
Hadoux J; Al Ghuzlan A; Lamartina L; Bani MA; Moog S; Attard M; Scoazec JY; Hartl D; Aldea M; Friboulet L; Jules-Clement G; Italiano A; Besse B; Lacroix L; Baudin E
JCO Precis Oncol; 2023 Sep; 7():e2300053. PubMed ID: 38127829
[TBL] [Abstract] [Full Text] [Related]
12. The Diagnostic Value of
Cui B; Wu Z; Yu B; Li Y; Liu H
Discov Med; 2023 Dec; 35(179):1064-1070. PubMed ID: 38058071
[TBL] [Abstract] [Full Text] [Related]
13. Esophagectomy Enhanced Recovery After Surgery Initiative Results in Improved Outcomes.
Sims CR; Abou Chaar MK; Kerfeld MH; Cassivi SD; Hofer RE; Nichols FC; Reisenauer J; Saddoughi SS; Shen KR; Stewart TM; Tapias LF; Wigle DA; Blackmon SH
Ann Thorac Surg; 2024 Apr; 117(4):847-857. PubMed ID: 38043851
[TBL] [Abstract] [Full Text] [Related]
14. The correlation between small papillary thyroid cancers and gamma radionuclides Cs-137, Th-232, U-238 and K-40 using spatially-explicit, register-based methods.
Bayadsi H; Brink PVD; Erlandsson M; Gudbjornsdottir S; Sebraoui S; Koorem S; Nordin P; Hennings J; Englund O
Spat Spatiotemporal Epidemiol; 2023 Nov; 47():100618. PubMed ID: 38042537
[TBL] [Abstract] [Full Text] [Related]
15. High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::alk rearrangement: Changes in genetic status using genetic testing during treatment with an alk inhibitor.
Watanabe T; Honma Y; Yonemori K; Sunami K; Yoshimoto S; Mori T
Head Neck; 2024 Mar; 46(3):E26-E31. PubMed ID: 38018800
[TBL] [Abstract] [Full Text] [Related]
16. cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in alk-rearrangement positive non-small cell lung cancer (NSCLC).
Lee SY; Cho HJ; Choi J; Ku B; Moon SW; Moon MH; Kim KS; Hyun K; Kim TJ; Sung YE; Hwang Y; Lee E; Ahn DH; Choi JY; Lim JU; Park CK; Kim SW; Kim SJ; Koo IS; Jung WS; Lee SH; Yeo CD; Lee DW
J Exp Clin Cancer Res; 2023 Nov; 42(1):309. PubMed ID: 37993887
[TBL] [Abstract] [Full Text] [Related]
17. Characterization of the Thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
[No Abstract] [Full Text] [Related]
18. Diagnostic Performance of Thyroid Nodule Risk Stratification Systems: Comparison of ACR-TIRADS, EU-TIRADS, K-TIRADS, and ATA Guidelines.
Yucel S; Balci IG; Tomak L
Ultrasound Q; 2023 Dec; 39(4):206-211. PubMed ID: 37918114
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid cancers.
Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
[No Abstract] [Full Text] [Related]
20. Therapeutic inhibition of ATR in differentiated thyroid cancer.
Lin SF; Lee YY; Wu MH; Lu YL; Yeh CN; Chen WY; Chou TC; Wong RJ
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902083
[TBL] [Abstract] [Full Text] [Related]
[Next]
